In my initial experience with psychedelics, a sudden violin sound made the sky transform into a vibrant yellow. Surreal images—like body parts floating away—briefly captured my attention.
In the days that followed, conversations with my guides and study staff helped me find humor in my situation: Breast cancer didn’t define me. It was more like a metaphor that provided a different perspective on my health challenges.
This was back in 2012 when I participated in the first psilocybin clinical trial at Johns Hopkins aimed at tackling cancer-related depression. The conditions for my sessions were ideal; I always had two trained guides, one male and one female, by my side. Following each session, I had thorough debriefings and support. A psychiatrist from another university who specializes in psychedelic research even spoke with me the next day, suggesting I look for community support once I returned to the U.K., where I was living.
Post-trial, I sought out additional psychedelic experiences (which weren’t part of the Hopkins study). Each one deepened my awareness of the universe’s vastness in its own way.
These realizations are characteristic of psychedelics: When used in suitable environments, they may provide relief from various emotional issues like depression and even help with addictions and anxiety, especially during palliative care. They seem to facilitate growth on emotional and social levels, and research indicates they promote neuroplasticity and neurogenesis.
Over the years since my first experience, I’ve been encouraged to see psychedelics gaining greater acceptance.
Yet, there’s a troubling trend emerging. Over the last decade, commercialization and misleading narratives about psychedelics have proliferated—ranging from high-end retreats to a rush of venture capitalists pursuing pharmaceutical monopolies. This often mirrors broader healthcare trends that favor efficiency over genuine human connection.
Some of the most powerful aspects of psychedelic experiences involve community and ritual, but since these can’t be easily monetized, many companies are ignoring them. Instead, they often opt for one-on-one therapeutic sessions with a few follow-up calls.
Despite marketing that centers on the efficacy of the drugs themselves, psychedelics aren’t cure-alls. Their effectiveness often hinges on the context in which they’re used. Ideally, they should be part of a culturally significant healing process, involving community figures and shared experiences in a dedicated space.
Practitioners emphasize the importance of creating a safe environment—a space and time where deep inner work can unfold. This concept integrates the ideas of ‘set’ (mindset) and ‘setting’ (the physical and social environment).
Following an intense psychedelic experience, it’s vital to have days set aside for integration. This is when individuals can process their insights before returning to their everyday lives.
During this phase, experienced guides encourage participants to reflect on their grand revelations. That’s where community and guidance come into play.
Other participants can help ground profound experiences, keeping egos in check. Insightful moments during sessions may lead participants to feel they hold universal truths that must be shared. Sometimes, they even believe they’ve acquired special abilities that the world should recognize.
Group dynamics are essential for a balanced experience. Participants can challenge and support one another, facilitating emotional growth in the aftermath.
When one pursues psychedelic therapy alone, they’re likely more vulnerable. Even well-meaning guides might cross emotional boundaries with participants who are in delicate states due to the drugs. These guides might expect too much sharing or push individuals out of their comfort zones.
Moreover, the psychedelic facilitation landscape lacks regulation, often leaving guides unprepared to handle complex emotional situations, especially those related to past traumas.
There’s also the risk posed by malevolent guides. For instance, Lykos Therapeutics faced scrutiny for not disclosing sexual abuse history at a Phase 2 study site during a crucial MDMA trial for PTSD.
It’s worth noting that not all psychedelics are alike. Their impacts vary significantly due to chemical differences. For example, MDMA is more of a synthetic stimulant than a true psychedelic like psilocybin or ayahuasca. It affects the brain in distinct ways compared to classic hallucinogens.
MDMA, in particular, can expose users to risks of abuse, as it significantly elevates oxytocin levels—a hormone involved in emotional bonding. People experience feelings of connection and openness, which could lead to vulnerability, especially because the drug alters brain activity in ways that differ from conventional psychedelics.
Those using MDMA for therapy need a robust support network throughout and after their sessions. Private one-on-one sessions can raise risks, making the integration process challenging.
Dr. Humphry Osmond, a British psychiatrist who participated in a peyote ceremony long ago, underscored the need for community and shared experiences during this journey. He noted that such ceremonies broaden one’s self-identity and deepen empathy.
The integration phase is crucial. Psychedelics amplify existing personality traits, whether positive or negative. This means that traits like kindness can shine, but darker tendencies can surface too. Without community support to contextualize these experiences, individuals might carry skewed self-views into their regular lives.
Examples of misuse abound, from cult leaders like Charles Manson to figures like Elon Musk, who illustrate the potential for harm when psychedelic experiences aren’t grounded in responsible practices.
Unfortunately, the qualities that enhance psychedelics’ effectiveness conflict with profit-driven models. The emphasis on individual gain often leads to isolation and feelings of neglect.
To maximize the potential of psychedelics, the community aspect—or “the village”—needs to be revitalized. It’s those collective and spiritual elements in community settings that alleviate suffering and reinforce connections.
